Life Tech expands in India; Natus hauls in record revenue;

@FierceMedDev: Thoratec's revenue keeps rising, fueled by HeartMate sales. How long can the surge last? More | Follow @FierceMedDev

@MarkHFierce: Smith & Nephew can thank emerging markets, in part, for steady Q2 growth. More from Bloomberg | Follow @MarkHFierce

@DamianFierce: KKR is buying another CRO, planning to merge RPS with PRA once the transactions close. Report | Follow @DamianFierce

> Abbott Laboratories ($ABT) ranks 7th among companies with tax haven subsidiaries, according to a new report. Story

> Advanced Circulatory secured $2 million in bridge funding to back the launch of its device designed to treat cardiac arrest. Story

> Natus Medical ($BABY) posted a record $82.3 million in second-quarter revenue, 35% over the previous year, and net income jumped to $4 million from $300,000 in 2012. Results

> Sequenom ($SQNM) and CombiMatrix ($CBMX) are joining forces to market chromosomal microarray analysis tests. News

> A group of researchers is developing a coating for medical devices designed to prevent infection relating to catheters, cardiac pacemakers and hip and knee prosthetics. Story

> Life Technologies ($LIFE) is launching a DNA forensics laboratory in India. Item

Biotech News

@FierceBiotech: PR: PharmAthene, Theraclone announce merger agreement to create #biologics co. targeting gov't and commerical markets. More | Follow @FierceBiotech

@JohnCFierce: Interesting to see Astra's Q2 report highlights late-stage deals. That took awhile. Makes a better case for near-term turnaround potential. | Follow @JohnCFierce

@RyanMFierce: Good time in biotech to find $: Karyopharm Therapeutics Secures $19 Million in Series B Financing Extension. Release | Follow @RyanMFierce

@EmilyMFierce: From FierceBiotechResearch.com: La Jolla, Kyowa Hakko Kirin partner on autoimmune disease drug discovery. Story | Follow @EmilyMFierce

> Analysis: AstraZeneca revs up new deals in shift to late-stage R&D turnaround. News

> Halozyme takes a second hit after safety fears scuttle PhII combo study. More

> Dicerna grabs $60M round to test RNAi tech on prime cancer suspect. Article

> Karyopharm snags $19M more to expand work on anticancer contender. Report

Pharma News

@FiercePharma: Wishful thinking or prophecy? Sanofi Q2 release titled "Last Quarter with Significant Negative Impact from the Patent Cliff." | Follow @FiercePharma

@CarlyHFierce:  Price controls in #India triggering confusion for companies and consumers alike. Item | Follow @CarlyHFierce

> Tension rises in China as officials fine J&J, visit Sanofi. News

> Gist of AstraZeneca's Q2 results: It could have been worse. More

Pharma Manufacturing News

> Fresenius cans managers tied to data manipulation. Article

> CEO says Hospira is making progress on manufacturing fixes. Report

> India's price controls trigger labeling confusion. Item

> European gene-therapy pioneer to expand manufacturing with U.S. plant. News

Vaccines News

> Sanofi, MedImmune begin shipping flu vaccines. Item

> National action plans needed to stop hepatitis B, WHO says. Story

> GSK, Pfizer commit more vaccines to Unicef program. Article

> CDC: U.S. 'dropping the ball' on HPV vaccinations. More

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.